Sepsis Diagnostics Market Research Report- Forecast to 2030

Sepsis Diagnostics Market Information, By Technology (Molecular Diagnostics, Biomarkers, Immunoassays and others), Type of Product (Kits, Instruments, Blood Culture Media and others), End Users (Pathology Laboratories, Specialty Clinics, Hospitals, Diagnostic Centers and others)- Forecast Till 2030

ID: MRFR/MED/1574-HCR | November 2022 | Region: Global | 85 Pages         

Sepsis Diagnostics Market

Sepsis Diagnostics Market is expected grow USD 1582.23 million at a CAGR 9.80% during the forecast 2021-2028

Segmentation

By Technology molecular diagnostics biomarkers Immunoassays
BY Type kits nstruments blood culture media
BY End User Pathology laboratories Specialty clinics hospitals diagnostic centers

Key Players

  • Scotland (US)
  • Sandstone Diagnostics Inc. (US)
  • T2 Biosystems
  • Inc. (US)
  • Immunexpress (US)
  • Axis-Shield Diagnostics Ltd. (Scotland)
  • Becton Dickinson and Company (US)
  • EKF Diagnostics (UK)
  • Cube Dx GmbH (Austria)
  • Wolters Kulwer N.V. (Netherlands)
  • Amara Health (US)

Drivers

  • The hospital-acquired infections and rising prevalence of sepsis
Speak to Analyst Request a Free Sample

Sepsis Diagnostics Market Overview


The sepsis diagnostics market is expected to gain a market value of USD 1,582.23 million by 2030 at a CAGR of 9.80% over the forecast period of 2022-2030.


Sepsis is a potentially fatal condition resulting from the body's immune system attacking its own tissues in response to an infection. Organs perform badly and inappropriately when the body's infection-fighting mechanisms are activated. Sepsis can lead to septic shock, and the unexpected drop in blood pressure can harm organs and even result in death.


The main growth factors in the global sepsis diagnostics market are the rising prevalence of sepsis, hospital-acquired infections, the rise in the number of sepsis procedures, and an increase in financing for sepsis-related research activities. The most typical consequence for individuals being treated in hospitals is an infection picked up there. According to the Centers for Disease Control and Prevention (CDC), between 2019 and 2020 in the United States, there was an increase of about 24%, 35%, and 15% in central line-associated bloodstream infections, ventilator-associated events, and Methicillin-resistant Staphylococcus Aureus (MRSA) bacteremia respectively. The use of sepsis diagnostic devices is expected to increase as bloodstream infections rise. However, the high price of molecular diagnostic testing and the shortage of skilled professionals are expected to hamper the growth.


COVID-19 Analysis


Increasing sepsis among COVID-19 patients positively impacted the market. In a report released by the CDC in 2021, the examination of the standardized infection ratios for acute care hospitals in 2020 revealed appreciable increases from 2019. The fourth quarter of 2020 had the biggest growth. Additionally, COVID-19 patients have the highest risk of acquiring sepsis, according to a study that PLOS published in August 2021. To quote the study, "Immunometabolic signatures predict the risk of progression to sepsis in COVID-19". So, it is expected that this will open up new prospects for unique diagnostics in the market under investigation.


Market Dynamics


Market Drivers


In the forthcoming years, the Sepsis Diagnostics Market is expected to reach new heights. Significant factors such as the increasing number of people suffering from sepsis, and diseases acquired from the hospital will drive the market. Also, the development of new diagnostic tools and treatments will further improve the market growth.


Restraints


However, there are some restraining factors such as the high costs of treatment will impact the market negatively. Also, the lack of standardization in various developing countries can hamper market growth.


Opportunities


The increasing awareness for healthcare and the population of the older generation is depicted to offer new opportunities. Also, the rising presence of resistant strains of bacteria and expenditure for development and research by key players and government will boost the Sepsis Diagnostics Market Growth.


Challenges


The lack of skilled professionals and awareness for new technology can be challenging for market growth.


Cumulative Analysis


The increasing cases of sepsis and emphasis on the development of treatment and diagnosis will propel the market in the upcoming years. Furthermore, the development by key players such as collaborations, acquisitions partnerships will have a positive effect on the market.


Value Chain Analysis


Wi0th the rising demand and growing awareness, it is depicted that Sepsis Diagnostics Market Trends will increase. Also, the rapid development in technology and awareness for the treatment is predicted to boost the market growth and value chain of the market.


Market Segmentations


The Sepsis Diagnostics Market Segment is divided into technology, test type, pathogen, method, product, and end-users.  Based on technology, the market is segmented into Immunoassays, Biomarkers, Diagnostics, and Others. 


Based on product type, the Market is segmented into Blood Culture, Instruments, Media, Kits, and Others.


Based on end-users, the Market is divided into Specialty Clinics, Diagnostic Centres, Pathology Laboratories, Hospitals, and Others.


Based on test types, the Market is segmented into Point-of-Care Test, Laboratory Test.


Based on the method, the market is segmented into Conventional Diagnostics and Automated Diagnostics.


Based on Pathogen, the market is divided into Fungal Sepsis, bacterial Sepsis, and others. The bacterial sepsis is divided into Gram-Positive Bacterial Sepsis and Gram-Negative Bacterial Sepsis.


Regional Analysis


The Sepsis Diagnostics Market Size based upon region is divided into Europe, Americas, Asia-Pacific, and Africa, and the Middle East. However, the Americas are further divided into Latin America, and North America. According to the Market Analysis, North America is evaluated to hold the largest share in the forecast period.  It is mainly because this region has a well-established infrastructure for healthcare and medical devices. Also, the increasing adoption of advanced technologies for sepsis diagnosis is favorable for the market growth.


Furthermore, Europe is also evaluated to hold the second-largest Sepsis Diagnostics Market Share. The growing adoption of new technologies and investments for development and research from various economies will be favorable for the market.


Asia-Pacific is evaluated to grow at the fastest CAGR. The growing awareness and the fast development in the healthcare system and technologies are anticipated to fuel the market growth. Moreover, Africa and the Middle East region is anticipated to grow at a gradual rate in the studied forecast period.


Competitive Landscape


The Market has the immense presence of various key players. These key players do various developments and market strategies such as collaboration, market analysis, launches, partnerships, etc. to enhancer their business withhold. Some of the key players in the market are as follows.



  • Scotland (US)

  • Sandstone Diagnostics Inc. (US)

  • T2 Biosystems, Inc. (US)

  • Immunexpress (US)

  • Axis-Shield Diagnostics Ltd. (Scotland)

  • Becton Dickinson and Company (US)

  • EKF Diagnostics (UK)

  • Cube Dx GmbH (Austria)

  • Wolters Kulwer N.V. (Netherlands)

  • Amara Health (US)

  • Alpa Laboratories Ltd. (India)

  • Abbott Laboratories (US)

  • CytoSorbents Corporation(US)

  • Beckmam Coulter Inc. (US)

  • Hoffman-La Roche AG (Switzerland)

  • Luminex Corporation (US)

  • EKF Diagnostics (UK)


Recent Developments



  • In June 2021, BioMérieux and Specific Diagnostics announced a co-exclusive distribution agreement for the SPECIFIC REVEAL Rapid AST system in Europe as part of the battle against antimicrobial resistance.

  • In May 2020, Beckman Coulter announced the availability of DxH 690T haematology analyzer featuring the early sepsis indicator in the United States, which has been designed to optimize workflow and reduce downtime in mid-volume laboratories.

  • In August 2019, Sepsis Alliance and bioMérieux, Inc., announced a strategic partnership to increase healthcare provider education on sepsis.

  • In August 2018, Sysmex Corporation announced the launch of HISCL Presepsin Assay Kit for bacterial sepsis testing.


Report Overview


The overview of the Sepsis Diagnostics Market Forecast is as follows.



  • Market Overview

  • COVID-19 Analysis

  • Dynamics of the Market

  • Value Chain Analysis

  • Market Segmentation

  • Regional Analysis

  • Competitive Analysis

  • Recent Development


Report Score and Segmentation


The report score of Sepsis Diagnostics Market Outlook highlights valuable information in the studied forecast period 2022-2030. It covers market value, CAGR, drivers, key players, challenges, and many more. Therefore, the information provided in this report is collected from various primary and secondary sources.


Segmentation


By Technology


  • Immunoassays

  • Biomarkers

  • Diagnostics

  • Others


By Product Type


  • Blood Culture

  • Instruments

  • Media

  • Kits

  • Others


By Test Type


  • Point-of-Care Test

  • Laboratory Test


By Method


  • Conventional Diagnostics

  • Automated Diagnostics


By Pathogen


  • Fungal Sepsis

  • Bacterial Sepsis

  • Others

  • Gram-Positive Bacterial Sepsis

  • Gram-Negative Bacterial Sepsis


By End-Users


  • Specialty Clinics

  • Diagnostic Centres

  • Pathology Laboratories

  • Hospitals

  • Others


By Region


  • Europe

  • Africa and the Middle East

  • Americas

  • Asia-Pacific



Report Scope:

Report Attribute/Metric Details
  Market Size   USD 1582.23 million
  CAGR   9.80% (2020-2030)
  Base Year   2019
  Forecast Period   2020-2030
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Technology, Type of Product and End Users
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   bioMérieux, Inc. (US), EKF Diagnostics (UK), Immunexpress (US), T2 Biosystems, Inc. (US), Becton, Dickinson and Company (US), Axis-Shield Diagnostics Ltd. (Scotland), Cube Dx GmbH (Austria), Sandstone Diagnostics, Inc. (US)
  Key Market Opportunities   joint ventures, strategic alliances, mergers and acquisitions, new product developments along with research and developments
  Key Market Drivers   The hospital-acquired infections and Rising prevalence of sepsis has led to a growing need for its early diagnosis


Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

Sepsis Diagnostics Market is projected grow at 9.80% CAGR during the assessment period (2022-2030).

The valuation of the sepsis diagnostics market is estimated to increase to USD 1582.23 MN by the end of 2030.

T2 Biosystems, Inc. (US), EKF Diagnostics (UK), bioMérieux, Inc. (US), Sandstone Diagnostics, Inc. (US), Becton, Dickinson and Company (US), Immunexpress (US), Cube Dx GmbH (Austria), and Axis-Shield Diagnostics Ltd. (Scotland), are some of the major players operating in the sepsis diagnostics market.

North America holds the largest share in the global sepsis diagnostics market, followed by Europe and the Asia Pacific, respectively.

Growing investments from industry players and the enhanced collection of patient outcome information and incorporation into medical records are the major tailwinds pushing the growth of the global sepsis diagnostics market.